Smithbridge Asset Management Inc Novo Nordisk A S Transaction History

Smithbridge Asset Management Inc

$573 Million
Q3 2024

A detailed history of Smithbridge Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 89,120 shares of NVO stock, worth $9.55 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares

89,120

Previous 92,327 3.47%

Holding current value

$9.55 Million

Previous $13.2 Million 19.48%

% of portfolio

1.85%

Previous 2.76%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$119.07 - $145.42 $381,857 - $466,361	-3,207 Reduced 3.47%	89,120 $10.6 Million
Q2 2024 Jul 19, 2024	SELL	$122.71 - $146.91 $20,369 - $24,387	-166 Reduced 0.18%	92,327 $13.2 Million
Q1 2024 May 03, 2024	SELL	$102.11 - $135.92 $319,400 - $425,157	-3,128 Reduced 3.27%	92,493 $11.9 Million
Q4 2023 Jan 18, 2024	SELL	$87.78 - $105.45 $145,451 - $174,730	-1,657 Reduced 1.7%	95,621 $9.89 Million
Q3 2023 Oct 25, 2023	BUY	$90.94 - $199.54 $4.29 Million - $9.42 Million	47,185 Added 94.19%	97,278 $8.85 Million
Q2 2023 Jul 20, 2023	SELL	$155.98 - $172.65 $562,619 - $622,748	-3,607 Reduced 6.72%	50,093 $8.11 Million
Q2 2023 Jul 18, 2023	BUY	$155.98 - $172.65 $345,807 - $382,765	2,217 Added 4.31%	53,700 $7.27 Million
Q1 2023 Apr 20, 2023	SELL	$132.34 - $159.14 $293,397 - $352,813	-2,217 Reduced 4.13%	51,483 $8.19 Million
Q4 2022 Mar 01, 2023	SELL	$102.55 - $135.33 $38,558 - $50,884	-376 Reduced 0.7%	53,700 $7.27 Million
Q3 2022 Oct 25, 2022	BUY	$95.28 - $116.93 $46,401 - $56,944	487 Added 0.91%	54,076 $5.39 Million
Q2 2022 Aug 03, 2022	SELL	$103.24 - $121.81 $34,172 - $40,319	-331 Reduced 0.61%	53,589 $5.97 Million
Q1 2022 Apr 25, 2022	SELL	$93.1 - $112.54 $28,395 - $34,324	-305 Reduced 0.56%	53,920 $5.99 Million
Q4 2021 Jan 24, 2022	SELL	$95.88 - $117.08 $232,413 - $283,801	-2,424 Reduced 4.28%	54,225 $6.07 Million
Q3 2021 Oct 04, 2021	SELL	$84.42 - $106.62 $171,119 - $216,118	-2,027 Reduced 3.45%	56,649 $5.44 Million
Q2 2021 Jul 23, 2021	BUY	$67.66 - $84.76 $35,995 - $45,092	532 Added 0.91%	58,676 $4.92 Million
Q1 2021 Apr 06, 2021	BUY	$67.06 - $75.82 $71,754 - $81,127	1,070 Added 1.87%	58,144 $3.92 Million
Q4 2020 Jan 21, 2021	SELL	$63.89 - $73.8 $38,653 - $44,649	-605 Reduced 1.05%	57,074 $3.99 Million
Q3 2020 Oct 29, 2020	SELL	$63.69 - $70.22 $10,827 - $11,937	-170 Reduced 0.29%	57,679 $4.01 Million
Q2 2020 Jul 01, 2020	SELL	$58.54 - $67.94 $298,554 - $346,494	-5,100 Reduced 8.1%	57,849 $3.79 Million
Q1 2020 Apr 13, 2020	SELL	$49.46 - $64.78 $328,661 - $430,463	-6,645 Reduced 9.55%	62,949 $3.79 Million
Q4 2019 Jan 09, 2020	SELL	$49.86 - $58.26 $355,252 - $415,102	-7,125 Reduced 9.29%	69,594 $4.03 Million
Q3 2019 Oct 15, 2019	BUY	$47.54 - $53.43 $37,794 - $42,476	795 Added 1.05%	76,719 $3.97 Million
Q2 2019 Jul 09, 2019	SELL	$46.79 - $52.47 $4,211 - $4,722	-90 Reduced 0.12%	75,924 $3.88 Million
Q1 2019 Apr 03, 2019	BUY	$46.36 - $52.63 $49,837 - $56,577	1,075 Added 1.43%	76,014 $3.98 Million
Q4 2018 Jan 15, 2019	BUY	$41.54 - $47.25 $66,297 - $75,411	1,596 Added 2.18%	74,939 $3.45 Million
Q3 2018 Oct 05, 2018	BUY	$46.76 - $51.24 $24,315 - $26,644	520 Added 0.71%	73,343 $3.46 Million
Q2 2018 Jul 18, 2018	BUY	$44.29 - $50.42 $21,702 - $24,705	490 Added 0.68%	72,823 $3.36 Million
Q1 2018 Apr 09, 2018	SELL	$48.49 - $58.14 $59,836 - $71,744	-1,234 Reduced 1.68%	72,333 $3.56 Million
Q4 2017 Jan 18, 2018	BUY	$47.53 - $53.73 $132,133 - $149,369	2,780 Added 3.93%	73,567 $3.95 Million
Q3 2017 Oct 12, 2017	BUY	$41.15 - $49.22 $2.91 Million - $3.48 Million	70,787	70,787 $3.41 Million

Others Institutions Holding NVO

# of Institutions

1,950

Shares Held

319M

Call Options Held

5.22M

Put Options Held

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $242B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Smithbridge Asset Management Inc with notifications on news.

Account

Smithbridge Asset Management Inc Novo Nordisk A S Transaction History